US Patent Issued to Tempus AI on Oct. 21 for "Systems and methods for predicting therapeutic sensitivity" (Illinois Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,451,250, issued on Oct. 21, was assigned to Tempus AI Inc. (Chicago).

"Systems and methods for predicting therapeutic sensitivity" was invented by Ameen Salahudeen (Oak Park, Ill.), Brian M. Larsen (Chicago), Michelle M. Stein (Morton Grove, Ill.), Luka A. Karginov (Westmont, Ill.), Madhavi Kannan (Chicago), Aly A. Khan (Chicago), Veronica Sanchez Freire (Chicago) and Yilin Zhang (Wilmette, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, systems, and software are provided for using organoid cultures, e.g., patient-derived tumor organoid cultures, to improve treatment predictions and outcomes."

The patent was filed on Oct. 22, 2020, under A...